Egr-1 is a key regulator of IL-17A-induced psoriasin upregulation in psoriasis

Experimental Dermatology

Volumn 23, Issue 12, 2014, Pages 890-895

  Jeong, Sang Hoon ^a   Kim, Hee Joo ^a   Jang, Yeonsue ^a   Ryu, Woo In ^a   Lee, Hana ^a   Kim, Jin Hee ^a   Bae, Hyun Cheol ^a   Choi, Jae Eun ^a   Kye, Young Chul ^a   Son, Sang Wook ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Egr 1; IL 17A; Keratinocytes; Psoriasin; Psoriasis

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; INTERLEUKIN 17; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PSORIASIN; STRESS ACTIVATED PROTEIN KINASE; EGR1 PROTEIN, HUMAN; EGR1 PROTEIN, MOUSE; IL17A PROTEIN, HUMAN; PROTEIN S 100; S100A7 PROTEIN, HUMAN; S100A7 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INNATE IMMUNITY; KERATINOCYTE; LEUKOCYTE ACTIVATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PATHOGENESIS; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSORIASIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION SITE; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CELL LINE; GENE SILENCING; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANIMALS; CELL LINE; EARLY GROWTH RESPONSE PROTEIN 1; FEMALE; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; INTERLEUKIN-17; KERATINOCYTES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; PSORIASIS; S100 PROTEINS; UP-REGULATION;

EID: 84913554948     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12554     Document Type: Article

References (39)

1. Lowes M A, Bowcock A M, Krueger J G. Nature 2007: 445: 866-873.
2. Nograles K, Zaba L, Guttman-Yassky E et al. Br J Dermatol 2008: 159: 1092-1102.
3. Watanabe H, Kawaguchi M, Fujishima S et al. J Invest Dermatol 2009: 129: 650-656.
4. Gaffen S L. Nat Rev Immunol 2009: 9: 556-567.
5. Guttman-Yassky E, Lowes M A, Fuentes-Duculan J et al. J Immunol 2008: 181: 7420-7427.
6. Harder J, Gläser R, Schröder J-M. J Endotoxin Res 2007: 13: 317-338.
7. Peric M, Koglin S, Dombrowski Y et al. PLoS ONE 2009: 4: e6340.
8. Thiel G, Cibelli G. J Cell Physiol 2002: 193: 287-292.
9. McMahon S B, Monroe J G. J Leukoc Biol 1996: 60: 159-166.
10. Harja E, Bucciarelli L G, Lu Y et al. Circ Res 2004: 94: 333-339.
11. Gong L-B, He L, Liu Y et al. World J Gastroenterol 2005: 11: 5022.
12. Fang M, Wee S A, Ronski K et al. Genomic Med 2007: 1: 75-85.
13. Mark E B, Jonsson M, Asp J et al. Arch Dermatol Res 2006: 297: 459-467.
14. Hoffmann H J, Olsen E, Etzerodt M, et al. J Invest Dermatol 1994: 103: 370-375.
15. Jinquan T, Vorum H, Larsen C G et al. J Invest Dermatol 1996: 107: 5-10.
16. Lee K C, Eckert R L. J Invest Dermatol 2007: 127: 945-957.
17. Harder J, Dressel S, Wittersheim M et al. J Invest Dermatol 2010: 130: 1355-1364.
18. Hegyi Z, Zwicker S, Bureik D et al. J Invest Dermatol 2012: 132: 1416-1424.
19. Wolf R, Howard O Z, Dong H-F et al. J Immunol 2008: 181: 1499.
20. Gläser R, Meyer-Hoffert U, Harder J et al. J Invest Dermatol 2009: 129: 641-649.
21. Johansen C, Kragballe K, Westergaard M et al. Br J Dermatol 2005: 152: 37-42.
22. Jeong S H, Park J H, Kim J N et al. Exp Dermatol 2010: 19: e206-e212.
23. McDonald J, Pilgram T. Histopathology 1999: 34: 439-446.
24. Roux P P, Blenis J. Microbiol Mol Biol Rev 2004: 68: 320-344.
25. de Jongh G J, Zeeuwen P L, Kucharekova M et al. J Invest Dermatol 2005: 125: 1163-1173.
26. Shubbar E, Vegfors J, Carlström M et al. Breast Cancer Res Treat 2012: 134: 71-80.
27. Zheng Y, Niyonsaba F, Ushio H et al. Immunology 2008: 124: 357-367.
28. Afzali B, Lombardi G, Lechler R et al. Clin Exp Immunol 2007: 148: 32-46.
29. Tesmer L A, Lundy S K, Sarkar S et al. Immunol Rev 2008: 223: 87-113.
30. Boniface K, Diveu C, Morel F et al. J Immunol 2007: 178: 4615-4622.
31. Li J, Chen Xe, Liu Z et al. J Huazhong Univ Sci Technolog Med Sci 2007: 27: 330-332.
32. Lowes M A, Kikuchi T, Fuentes-Duculan J et al. J Invest Dermatol 2008: 128: 1207-1211.
33. Zaba L C, Cardinale I, Gilleaudeau P et al. J Exp Med 2007: 204: 3183-3194.
34. Gutowska-Owsiak D, Schaupp A L, Salimi M et al. Exp Dermatol 2012: 21: 104-110.
35. Granet C, Maslinski W, Miossec P. Arthritis Res Ther 2004: 6: R190-R198.
36. Granet C, Miossec P. Cytokine 2004: 26: 169-177.
37. Mose M, Kang Z, Raaby L et al. Exp Dermatol 2013: 22: 476-481.
38. Gröne A. Vet Immunol Immunopathol 2002: 88: 1-12.
39. Di Cesare A, Di Meglio P, Nestle F O. J Invest Dermatol 2009: 129: 1339-1350.